• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】11059

【品名】Cyclohexanone

【CA登记号】108-94-1

【 分 子 式 】C6H10O

【 分 子 量 】98.1448

【元素组成】C 73.43% H 10.27% O 16.3%

与该中间体有关的原料药合成路线共 36 条

合成路线1

该中间体在本合成路线中的序号:(A)

The reaction of pregnenolone (I) with I2 and pyridine at 90 C gives (3beta-hydroxypregn-5-en-20-one-21-yl)pyridinium iodide (II), which by treatment with sodium methoxide in refluxing methanol is converted into methyl 5-androsten-3beta-ol-17beta-carboxylate (III). The Meerwein-Poundorf oxidation of (III) with cyclohexanone (A) and aluminum isopropoxide in refluxing toluene yields methyl 4-androsten-3-one-17beta-carboxylate (IV), which is hydrolyzed with KOH in refluxing methanol - water to the corresponding free acid (3-oxo-4-etienic acid) (V). The reaction of (V) with oxalyl chloride (B) and diethylamine in refluxing toluene affords 17beta-(N,N-diethylcarbamoyl)-4-androstene-3-one (VI), which is oxidized with O3 or with NaIO4 and KMnO4 giving 17beta-(N,N-diethylcarbamoyl)-5-oxo-3,5-secoandrostan-3-oic acid (VII). The cyclization of (VII) with methylamine ethylene glycol at 180 C in a pressure vessel affords 17beta-(N,N-diethylcarbamoyl)-4-methyl-4-aza-5-androsten-3-one (VIII), which is finally reduced with H2 over Pt in acetic acid. The cyclization of the acid (VII) with NH3 in ethanol at 180 C in a pressure vessel gives 17beta-(N,N-diethylcarbamoyl)-4-aza-5-androsten-3-one (IX), which is reduced with H2 over Pt in acetic acid yielding 17beta-(N,N-diethylcarbamoyl)-4-aza-5alpha-androstan-3-one (X). Finally, this compound is methylated with CH3I by means of NaH in toluene.

1 Hillier, K.; Blancafort, P.; Serradell, M.N.; Castaner, J.; 4-MA. Drugs Fut 1983, 8, 4, 323.
2 Jobson, R.B.; Johnston, D.B.R.; Rasmusson, G.H.; Reinhold, D.F.; Utne, T. (Merck & Co., Inc.); Preparation of 4-aza-17-substituted-5 alpha -androstan-3-ones useful as 5 alpha -reductase inhibitors. US 4220775 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(B) 29841 Oxalyl chloride; 2-Chloro-2-oxoacetyl chloride 79-37-8 C2Cl2O2 详情 详情
(I) 36070 1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-ethanone 145-13-1 C21H32O2 详情 详情
(II) 36071 1-[2-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl]pyridinium iodide C26H36INO2 详情 详情
(III) 36072 Methyl 3[beta]-hydroxyandrost-5-ene- 17[beta]carboxylate; methyl (3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate 7254-03-7 C21H32O3 详情 详情
(IV) 14899 methyl (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate C21H30O3 详情 详情
(V) 14892 (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid; 4-Androstene-3-oxo-17-beta-carboxylic acid 7385-78-6 C20H28O3 详情 详情
(VI) 36073 (8S,9S,10R,13S,14S,17S)-N,N-diethyl-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxamide C24H37NO2 详情 详情
(VII) 36074 3-[(3S,3aS,5aS,6R,9aS,9bS)-3-[(diethylamino)carbonyl]-3a,6-dimethyl-7-oxododecahydro-1H-cyclopenta[a]naphthalen-6-yl]propionic acid C23H37NO4 详情 详情
(VIII) 36075 (4aR,4bS,6aS,7S,9aS,9bS)-N,N-diethyl-1,4a,6a-trimethyl-2-oxo-2,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide C24H38N2O2 详情 详情
(IX) 36076 (4aR,4bS,6aS,7S,9aS,9bS)-N,N-diethyl-4a,6a-dimethyl-2-oxo-2,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide C23H36N2O2 详情 详情
(X) 36077 (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N,N-diethyl-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide C23H38N2O2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(IX)

The condensation of 4-[2-(acetylamino)ethyl]benzenesulfonyl chloride (I) with 1-cyclohexyl-2-iminoimidazolidine (III) by means of NaOH in refluxing acetone gives 1-[[4-(2-acetamidoethyl)phenyl]sulfonyl]-3-cyclohexyl-2-iminoimidazolidine (III), which is hydrolyzed with refluxing 2N HCl yielding 1-[[4-(2-aminoethyl)phenyl]sulfonyl]-3-cyclohexyl-2-iminoimidazolidine (IV). Finally, this compound is acylated with crotonic anhydride (V) in dioxane. The starting products (I) and (II) are obtained as follows: 1) The acetylation of 2-phenylethylamine (VI) with acetic anhydride gives N-(2-phenylethyl)acetamide (VII), which is sulfonated with chlorosulfonic acid yielding compound (I). 2) The reductocondensation of cyclohexanone (IX) with ethylenediamine (VIII) gives N-cyclohexylethylenediamine (X), which is then cyclized with cyanogen chloride to compound (II).

1 Lehmann, C.; Dietrich, H.; Schweizer, E.H.; Marki, F.; Sulfonyliminoimidazolidines. A new clas of oral hypoglycemic agents. I. 1-[[p-[2-(Acylamino)ethyl]phenyl]sulfonyl]-2-iminoimidazolidies. J Med Chem 1983, 26, 7, 964-970.
2 Serradell, M.N.; Castaner, J.; Thorpe, P.J.; CGP-11112. Drugs Fut 1984, 9, 5, 315.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIIII) 14754 ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine 107-15-3 C2H8N2 详情 详情
(I) 34181 4-[2-(acetamido)ethyl]benzenesulfonyl chloride C10H12ClNO3S 详情 详情
(II) 34182 1-cyclohexyl-2-imidazolidinimine C9H17N3 详情 详情
(III) 34183 N-[4-[(3-cyclohexyl-2-imino-1-imidazolidinyl)sulfonyl]phenethyl]acetamide C19H28N4O3S 详情 详情
(IV) 34184 2-[4-[(3-cyclohexyl-2-imino-1-imidazolidinyl)sulfonyl]phenyl]-1-ethanamine; 4-[(3-cyclohexyl-2-imino-1-imidazolidinyl)sulfonyl]phenethylamine C17H26N4O2S 详情 详情
(V) 34185 (E)-2-butenoic anhydride C8H10O3 详情 详情
(VI) 18333 Phenethylamine; 2-Phenyl-1-ethanamine 64-04-0 C8H11N 详情 详情
(VII) 34186 N-phenethylacetamide 877-95-2 C10H13NO 详情 详情
(IX) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(X) 34187 N(1)-cyclohexyl-1,2-ethanediamine; N-(2-aminoethyl)-N-cyclohexylamine C8H18N2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

The condensation of m-methoxybenzaldehyde (I) with cyclohexanone (II) by means of KOH in refluxing water gives m-methoxybenzalcyclohexanone (III), which by reaction first with dimethylamine (A) in ether and then reduction with LiAlH4 in the same solvent affords cis-2-(alpha-dimethylamino-m-methoxybenzyl)cyclohexanol (IV). The hydrolysis of (IV) with HCl in isopropanol yields the racemic product, which is finally resolved into the corresponding optical isomers with tartaric acid.

1 Yardley, J.P.; Russell, P.B.; US 3928626 .
2 Paton, D.M.; Castaner, J.; Ciramadol. Drugs Fut 1980, 5, 6, 283.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20589 3-methoxybenzaldehyde; m-Anisaldehyde 591-31-1 C8H8O2 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 39125 2-[(E)-(3-methoxyphenyl)methylidene]cyclohexanone C14H16O2 详情 详情
(IV) 19943 5-(benzyloxy)-5-oxopentanoic acid C12H14O4 详情 详情
(V) 39126 (1R,2R)-2-[(R)-(dimethylamino)(3-methoxyphenyl)methyl]cyclohexanol C16H25NO2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Reaction of cyclohexenone (I) with ethyl cyanoacetate (A) in the presence of ammonia affords the Guareschi salt (II), which is hydrolyzed and decarboxylated to give 1,1-cyclohexanediacetic acid (III). The anhydride (IV) can be treated either with methanol to yield the halfester (V), or with hydroxylamine to afford the N-hydroxyimide (VII). The halfester (V) is subjected to a Curtius type rearrangement to give the isocyanate (VI), which is hydrolyzed to the amino acid hydrochloride (Xl).

1 Satzinger, G.; Hartenstein, J. (Pfizer Inc.); Cyclic sulphonyloxyimides. DE 2611690; ES 457050; FR 2344540; GB 1575709; JP 52113977; US 4152326 .
2 Satzinger, G.; Hartenstein, J.; Herrmann, M.; Heldt, W. (Pfizer Inc.); Cyclic aminoacids. DE 2460891; ES 443723; FR 2294697; GB 1465229; JP 51088940; US 4024175 .
3 Castaner, J.; Serradell, M.N.; Gabapentin. Drugs Fut 1984, 9, 6, 418.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(I) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(II) 30541 3',5'-Dicyano-2',4'-dioxospiro[cyclohexane-1,4'-piperidide] ammonium salt C12H16N4O2 详情 详情
(III) 30542 2-[1-(2-hydroxy-2-oxoethyl)cyclohexyl]acetic acid 4355-11-7 C10H16O4 详情 详情
(IV) 30543 3-oxaspiro[5.5]undecane-2,4-dione C10H14O3 详情 详情
(V) 30544 2-[1-(2-methoxy-2-oxoethyl)cyclohexyl]acetic acid C11H18O4 详情 详情
(VI) 30545 methyl 2-[1-(isocyanatomethyl)cyclohexyl]acetate C11H17NO3 详情 详情
(XI) 30546 2-[1-(aminomethyl)cyclohexyl]acetic acid 60142-96-3 C9H17NO2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

The same product can be obtained from reaction of cyclohexenone (I) with ethyl cyanoacetate (A) in the presence of ammonia affords the Guareschi salt (II), which is hydrolyzed and decarboxylated to give 1,1-cyclohexanediacetic acid (III). The anhydride (IV) can be treated with the N-hydroxyimide (VII) via a Lossen type rearrangement by conversion of (VII) to N-benzenesulfonyloxylmide (VIII) and subsequent reaction with triethylamine in methanol followed by hydrolysis of the urethanester (IX). The free amino acid is finally obtained from the hydrochloride (X) via anion exchange.

1 Satzinger, G.; Hartenstein, J. (Pfizer Inc.); Cyclic sulphonyloxyimides. DE 2611690; ES 457050; FR 2344540; GB 1575709; JP 52113977; US 4152326 .
2 Satzinger, G.; Hartenstein, J.; Herrmann, M.; Heldt, W. (Pfizer Inc.); Cyclic aminoacids. DE 2460891; ES 443723; FR 2294697; GB 1465229; JP 51088940; US 4024175 .
3 Castaner, J.; Serradell, M.N.; Gabapentin. Drugs Fut 1984, 9, 6, 418.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(I) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(II) 30541 3',5'-Dicyano-2',4'-dioxospiro[cyclohexane-1,4'-piperidide] ammonium salt C12H16N4O2 详情 详情
(III) 30542 2-[1-(2-hydroxy-2-oxoethyl)cyclohexyl]acetic acid 4355-11-7 C10H16O4 详情 详情
(IV) 30543 3-oxaspiro[5.5]undecane-2,4-dione C10H14O3 详情 详情
(VII) 30547 3-hydroxy-3-azaspiro[5.5]undecane-2,4-dione C10H15NO3 详情 详情
(VIII) 30548 3-[(phenylsulfonyl)oxy]-3-azaspiro[5.5]undecane-2,4-dione C16H19NO5S 详情 详情
(IX) 30549 methyl 2-(1-[[(methoxycarbonyl)amino]methyl]cyclohexyl)acetate C12H21NO4 详情 详情
(X) 30546 2-[1-(aminomethyl)cyclohexyl]acetic acid 60142-96-3 C9H17NO2 详情 详情

合成路线6

该中间体在本合成路线中的序号:

The reaction of 3beta-hydroxy-15beta,16beta-methylene-5-androsten-17-one (I) with 1-bromo-3,3 dimethoxypropane (II) by means of Li in THF gives the corresponding 3,3-dimethoxypropyl derivative (III), which by cyclization with acetic acid is converted to the lactol (IV). Oxidation of (IV) with cyclohexanone and aluminum isopropoxide in refluxing toluene yields 15beta,16beta-methylene-4-androstene[17(beta-1')-spiro)-5']perhydrofuran-2',3-dione (V), which is dehydrogenated with chloranil in refluxing tert-butanol to the 4,6-androstadiene (VI). Cyclopropanation of (VI) with trimethylsolfoxoniurn iodide (A) and NaH in DMSO affords the 6beta,7beta:15beta,16beta-dimethylene compound (VII), which is finally dehydrogenated by means of 2,3-dichloro-5,6-dicyanobenzoquinone in refluxing dioxane.

1 Petzoldt, K.; Wiechert, R.; Laurent, H.; A new synthesis for aldosterone-antagonistic spirorenone. Angew Chem 1983, 95, 5, 413-414.
2 Wiechert, R.; et al. (Schering AG); 6beta,7beta;15,16-Dimethylene-1,4-androstadien-3-ones, their preparation and use as medicinal agents. DE 2922500; EP 0019690; JP 55162799 .
3 Serradell, M.N.; Robinson, C.P.; Castaner, J.; Spirorenone. Drugs Fut 1985, 10, 6, 478.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
21890 2,3-dichloro-5,6-dicyano-1,4-benzoquinone; 4,5-dichloro-3,6-dioxo-1,4-cyclohexadiene-1,2-dicarbonitrile 84-58-2 C8Cl2N2O2 详情 详情
21891 2,3,5,6-Tetrachloro-1,4-benzoquinone; 2,3,5,6-Tetrachlorobenzo-1,4-quinone; p-Chloranil 118-75-2 C6Cl4O2 详情 详情
(A) 29693 Trimethylsulfoxonium iodide 1774-47-6 C3H9IOS 详情 详情
(I) 29688 (4aR,4bS,6aS,7aS,8aS,8bR,8cR)-2-hydroxy-4a,6a-dimethyl-2,3,4,4a,4b,5,6,6a,7a,8,8a,8b,8c,9-tetradecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(1H)-one C20H28O2 详情 详情
(II) 29689 3-bromo-1,1-dimethoxypropane; 3-bromo-1-methoxypropyl methyl ether 36255-44-4 C5H11BrO2 详情 详情
(III) 29690 (4aR,4bS,6aS,7S,7aS,8aS,8bR,8cR)-7-(3,3-dimethoxypropyl)-4a,6a-dimethyl-1,2,3,4,4a,4b,5,6,6a,7,7a,8,8a,8b,8c,9-hexadecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthrene-2,7-diol C25H40O4 详情 详情
(IV) 29691 3-Hydroxycyclopropa[1',2':15-beta,16-beta]pregn-5-ene-21,17-carbolactone C23H34O3 详情 详情
(V) 29692 3-Oxo-cyclopropa[1',2':15-beta,16-beta]pregn-4-ene-21,17-carbolactone C23H30O3 详情 详情
(VI) 11776 3-Oxo-cyclopropa[1',2':15-beta,16-beta]pregan-4,6-diene-21,17-carbolactone C23H28O3 详情 详情
(VII) 29694 3-Oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-17alpha-dicyclopropa-[6,7:15,16]pregn-4-ene-21,17-carbolactone C24H30O3 详情 详情

合成路线7

该中间体在本合成路线中的序号:(IV)

Reaction of 3-bromoanisole (I) with Mg turnings in refluxing THF provides Grignard reagent (II), which is converted into tramadol base (VI) by treatment with Mannich base (III) (obtained in turn via Mannich reaction of cyclohexanone (IV) with dimethylamine hydrochloride and formaldehyde). Alternatively, the transformation of (II) into (VI) can be performed by first treatment of (II) with additive TDA-1 (tris(2-(2-methoxyethoxy)ethylamine) to form complex (V), followed by addition of Mannich base (III). Alternatively, the additive used can be replaced by the following reagents: 1-methylimidazole, diglyme, 4-methylmorpholine, diazabicyclo(5.4.0)undec-7-ene, triethylamine, N,N,N',N',N''-pentamethyldiethylenetriamine, pyridine, 1,2-dimethylimidazole, 1-methylpyrrolidine, 1,4-dimethylpiperazine, pyrazine, S-(-)-nicotine, 1-methylpyrrole, 4-methoxypyridine, quinoline, 1,5-diazabicyclo(4.3.0)non-5-ene, 1-benzylimidazole or 1-butylimidazole. Once tramadol base (VI) is obtained, treatment with HCl in acetonitrile or isopropanol allows formation of the corresponding hydrochloride salt as an isomeric mixture of the trans/cis forms (VII). The desired isomer cis-(XII) can be obtained by many different routes: (a) recrystallization of (VII) from acetonitrile. (b) recrystallization of (VII) from dioxane/H2O. (c) recrystallization of (VII) from isopropanol. (d) heating of the mixture (VI) with p-toluenesulfonic acid or phosphoric acid or formic acid, followed by a recrystallization process. (e) treatment of (VII) with acetic anhydride in DMF, followed by crystallization from isopropanol. (f) treatment of (VII) with thionyl chloride in chlorobenzene, followed by crystallization from isopropanol. (g) treatment of (VII) with trifluoroacetic acid and sodium azide, followed by basification with K2CO3 and final recrystallization from isopropanol. (h) formation of tramadol hydrate (VIII) by treatment with water in diisopropyl ether, followed by hydrochloride formation with HCl. (i) formation of tramadol hydrobromide (IX) by treatment with hydrobromic acid, filtration of the solid obtained, obtaining of the free base by treatment with NaOH (5) and final conversion into the hydrochloride form by means of HCl. (j) formation of tramadol hydroiodide (X) by treatment with hydroiodic acid, filtration of the solid obtained and final conversion into the hydrochloride form by means of HCl.

1 Cherkez, S.; Lerman, O.; Tennenbaum, M.; Avner, H.; Kunyevski, T.; Process for the purification of 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol and its salts. US 5414129 .
2 Flick, K.; Frankus, E. (Grunenthal GmbH); 1-(m-Substd. phenyl)-2-aminomethyl cyclohexanols. US 3652589 .
3 Cabri, W.; Magrone, D.; Process for the separation of the (RR,SS)-2-(dimethylamino)methyl-1-(3-methoxyphenyl)cyclohexanol isomer from the (RS,SR) isomer by selective precipitation. EP 0940385 .
4 Lerman, O.; Kaspi, J.; Brenner, D.; Process for the purification of (RR,SS)-2-dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexanol hydrochloride. EP 0831082 .
5 Mitchell, M.; Archer, N.; Hurley, B.; Ogden, H.; Purification of tramadol. WO 9936389 .
6 Anderson, K.E.; Preparation and purification process for 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol and its salts. US 5877351 .
7 Mitchell, M.; Archer, N.; Ogden, H.; Cairns, S.; Purification of tramadol. WO 9936390 .
8 Jarvi, E.T.; Grayson, N.A.; Halvachs, R.E. (Mallinckrodt Medical Inc.); An improved synthesis and purification of (R*,R*)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol hydrochloride. WO 9961405 .
9 Gal, E.; Lerman, O.; Tennenbaum, M.; Kaspi, J.; Process for the purification of (RR,SS)-2-dimethylaminomethyl-(1-(3-methoxyphenyl)cyclohexanol and its salts. EP 0778262 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIIa), (VIII), (IX) 53884 (1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol n/a C16H25NO2 详情 详情
(VIIb) 53886 (1R,2S)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol n/a C16H25NO2 详情 详情
(I) 35983 m-bromoanisole; 1-Bromo-3-methoxybenzene; 3-Bromoanisole; 3-Bromophenyl methyl ether 2398-37-0 C7H7BrO 详情 详情
(II) 35984 bromo(3-methoxyphenyl)magnesium 36282-40-3 C7H7BrMgO 详情 详情
(III) 53883 2-(Dimethylaminoethyl)-1-cyclohexanone n/a C9H17NO 详情 详情
(IV) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(V) 53882   n/a C18H32BrMgNO7 详情 详情
(VI) 53885 Tramadol 22204-88-2 C16H25NO2 详情 详情

合成路线8

该中间体在本合成路线中的序号:(I)

The condensation of cyclohexanone (I) with 4 methoxyphenylacetonitrile (II) by means of n-butyllithium in THF gives 2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl) acetonitrile (III), which is reduced with H2 over Rh/A12O3 in ethanol-ammonia yielding 1-[2-amino-1-(4 methoxyphenyl)ethyl]cyclohexanol (IV). Finally, this compound is methylated with formaldehyde and formic acid in refluxing water.

1 Husbands, G.E.; et al.; Novel phenethylamine antidepressants. 190th ACS Natl Meet (Chicago) 1985, 20, 29-30, Abst MEDI 80.
2 Morris, G.E.; Muth, E.A.; Yardley, J.P. (American Home Products Corp.); Phenethylamine derivs.. EP 0112669; ES 8702336; GB 2133788; JP 1991135948; JP 1991178953; US 4535186 .
3 Prous, J.; Castaner, J.; WY-45030. Drugs Fut 1988, 13, 9, 839.
4 Yardley, J.P.; Husbands, G.E.M.; Stack, G.; et al.; 2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: Synthesis and antidepressant activity. J Med Chem 1990, 33, 10, 2899-905.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(II) 23242 2-(4-methoxyphenyl)acetonitrile; 4-methoxybenzeneacetonitrile 104-47-2 C9H9NO 详情 详情
(III) 23243 2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)acetonitrile C15H19NO2 详情 详情
(IV) 23244 1-[2-amino-1-(4-methoxyphenyl)ethyl]cyclohexanol 93413-77-5 C15H23NO2 详情 详情

合成路线9

该中间体在本合成路线中的序号:(II)

The condensation of 2-(4-methoxyphenyl)-N,N-dimethylthioacetamide (I) with cyclohexanone (II) by means of isopropylmagnesium bromide in toluene/methyl tert-butyl ether gives 2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)-N,N-dimethylthioacetamide (III), which is finally desulfurized by means of Raney-nickel in dioxane/acetic acid.

1 Shepard, R.G. (John Wyeth & Brother Ltd.); Preparation of cyclohexanol derivs. and novel thioamide intermediates. US 5043466 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 45364 2-(4-methoxyphenyl)-N,N-dimethylethanethioamide C11H15NOS 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 45365 2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)-N,N-dimethylethanethioamide C17H25NO2S 详情 详情

合成路线10

该中间体在本合成路线中的序号:(II)

1) The condensation of (S)-L-malic acid (I) and cyclohexanone (II) by means of boron trifluoride etherate gives the cyclic lactone (III), which is reduced by borane and treated with tert-butyldiphenylchlorosilane yielding the silyl ether (IV). The transesterification of (IV) with sodium methoxide in methanol affords 4-(tert-butyldiphenylsilyloxy)-2(S)-hydroxybutyric acid methyl ester (V), which is reduced with borane as before and esterified with naphthalenesufonyl chloride to give the sulfonate (VI). The treatment of (VI) with sodium methoxide affords the epoxide (VII), which is alkylated with decyllithium yielding 1-(tert-butyldiphenylsilyloxy)tetradecan-3(R)-ol (VIII). The benzylation of (VIII) with benzyl trichloroacetimidate (BTA) gives the benzyl ether (IX), which is desilylated with HF in acetonitrile yielding 3(R)-benzyloxytetradecan-1-ol (X). The oxidation of (X) with PDC gives 3(R)-benzyloxytetradecanal (XI), which is condensed with 1-(trimethylsilyl)-2(E)-nonene (XII) by means of a titanium dichloride complex yielding the diastereoisomeric mixture of alcohols (3R,4S,6R)- (XIII) and (3S,4S,6R)- (XIV), which are separated by column chromatography. The silylation of both isomers with tert-butyldimethylsilyl chloride affords both isomers (XV) and (XVI), which are ozonolyzed with O3 and oxidized with NaClO2 to yield the corresponding acids (XVII) and (XVIII). The desilylation of (XVII) and (XVIII) with HF in acetonitrile gives the hydroxy acids (XIX) and (XX), which are cyclized by means of benzenesulfonyl chloride and pyridine to the isomeric oxetanones (XXI) and (XXII). The unwanted isomer (XXII) can be isomerized by means of lithium diisopropylamide in THF to the correct isomer (XXI). The debenzylation of (XXI) by hydrogenation with H2 over Pd/C affords (3S,4S)-3-hexyl-4-[2(R)-hydroxytridecyl]oxetan-2-one (XXIII), which is finally condensed with N-formyl-L-leucine (XXIV) by means of diethyl azodicarboxylate (DEAD) in THF.

1 Barbier, P.; Schneider, F.; Widmer, U. (F. Hoffmann-La Roche AG); Process for the preparation of oxetanones. EP 0189577 .
2 Prous, J.; Mealy, N.; Castaner, J.; Orlistat. Drugs Fut 1994, 19, 11, 1003.
3 Tehim, A.; Chen, P.; Hanessian, S.; Total synthesis of (-)-tetrahydrolipstatin. J Org Chem 1993, 58, 27, 7768-81.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11058 (S)-(+)-Hydroxysuccinic acid; (S)-(+)-Malic acid; (S)-(+)-2-Hydroxybutanedioic acid; L-(-)-Apple acid 97-67-6 C4H6O5 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 11060 2-[(2S)-3-Oxo-1,4-dioxaspiro[4.5]dec-2-yl]acetic acid C10H14O5 详情 详情
(IV) 11061 (3S)-3-(2-[[tert-Butyl(diphenyl)silyl]oxy]ethyl)-1,4-dioxaspiro[4.5]decan-2-one C26H34O4Si 详情 详情
(V) 11062 methyl (2S)-4-[[tert-butyl(diphenyl)silyl]oxy]-2-hydroxybutanoate C21H28O4Si 详情 详情
(VI) 11063 (1R)-3-[[tert-butyl(diphenyl)silyl]oxy]-1-hydroxypropyl 2-naphthalenesulfonate C29H32O5SSi 详情 详情
(VII) 11064 tert-Butyl(diphenyl)silyl 2-[(2S)oxiranyl]ethyl ether; tert-Butyl[2-[(2S)oxiranyl]ethoxy]diphenylsilane C20H26O2Si 详情 详情
(VIII) 11065 (3R)-1-[[tert-Butyl(diphenyl)silyl]oxy]-3-tetradecanol C30H48O2Si 详情 详情
(IX) 11066 Benzyl (1R)-1-(2-[[tert-butyl(diphenyl)silyl]oxy]ethyl)dodecyl ether; [[(3R)-3-(Benzyloxy)tetradecyl]oxy](tert-butyl)diphenylsilane C37H54O2Si 详情 详情
(X) 11067 (3R)-3-(Benzyloxy)-1-tetradecanol C21H36O2 详情 详情
(XI) 11068 (3R)-3-(Benzyloxy)tetradecanal C21H34O2 详情 详情
(XII) 11069 Trimethyl[(E)-2-nonenyl]silane C12H26Si 详情 详情
(XIII) 11070 (3R,4S,6R)-6-(Benzyloxy)-3-hexyl-1-heptadecen-4-ol C30H52O2 详情 详情
(XIV) 11071 (3S,4S,6R)-6-(Benzyloxy)-3-hexyl-1-heptadecen-4-ol C30H52O2 详情 详情
(XV) 11072 ([(1S,2R)-1-[(2R)-2-(Benzyloxy)tridecyl]-2-hexyl-3-butenyl]oxy)(tert-butyl)dimethylsilane; benzyl (1R,3S,4R)-3-[[tert-Butyl(dimethyl)silyl]oxy]-4-hexyl-1-undecyl-5-hexenyl ether C36H66O2Si 详情 详情
(XVI) 11073 ([(1S,2S)-1-[(2R)-2-(Benzyloxy)tridecyl]-2-hexyl-3-butenyl]oxy)(tert-butyl)dimethylsilane; benzyl (1R,3S,4S)-3-[[tert-Butyl(dimethyl)silyl]oxy]-4-hexyl-1-undecyl-5-hexenyl ether C36H66O2Si 详情 详情
(XVII) 11074 (2S,3S,5R)-5-(Benzyloxy)-3-[[tert-butyl(dimethyl)silyl]oxy]-2-hexylhexadecanoic acid C35H64O4Si 详情 详情
(XVIII) 11075 (2R,3S,5R)-5-(Benzyloxy)-3-[[tert-butyl(dimethyl)silyl]oxy]-2-hexylhexadecanoic acid C35H64O4Si 详情 详情
(XIX) 11076 (2S,3S,5R)-5-(Benzyloxy)-2-hexyl-3-hydroxyhexadecanoic acid C29H50O4 详情 详情
(XX) 11077 (2R,3S,5R)-5-(Benzyloxy)-2-hexyl-3-hydroxyhexadecanoic acid C29H50O4 详情 详情
(XXI) 11078 (3S,4S)-4-[(2R)-2-(Benzyloxy)tridecyl]-3-hexyl-2-oxetanone C29H48O3 详情 详情
(XXII) 11079 (3R,4S)-4-[(2R)-2-(Benzyloxy)tridecyl]-3-hexyl-2-oxetanone C29H48O3 详情 详情
(XXIII) 11080 (3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone C22H42O3 详情 详情
(XXIV) 11081 N-Formyl-L-leucine; (2S)-2-(Formylamino)-4-methylpentanoic acid 6113-61-7 C7H13NO3 详情 详情

合成路线11

该中间体在本合成路线中的序号:(II)

In an alternative method, condensation of semicarbazide hydrochloride (I) with cyclohexanone (II) yields the semicarbazone (III). Subsequent reaction of (III) with ethyl chloroacetate (IV) in the presence of NaOMe gives rise to the cyclohexylidene aminohydantoin (V). Treatment of (V) with 5-(p-nitrophenyl)furfural (VI) under acidic conditions affords the furfurylidene aminohydantoin (VII). This is finally converted into the corresponding sodium salt employing methanolic NaOMe (3).

1 Martin-Escudero Perez, U.; Izquierdo Sanjose, M.; Process for obtaining 1-[(5-(p-nitrophenyl)furfuryliden)amino]hydantoin and its sodium salt. ES 458000 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 23944 1-Hydrazinecarboxamide 563-41-7 CH5N3O 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 63587 2-cyclohexylidene-1-hydrazinecarboxamide C7H13N3O 详情 详情
(IV) 16601 ethyl chloroacetate; ethyl 2-chloroacetate 105-39-5 C4H7ClO2 详情 详情
(V) 63588 1-(cyclohexylideneamino)-2,4-imidazolidinedione C9H13N3O2 详情 详情
(VI) 63583 5-(4-nitrophenyl)-2-furaldehyde C11H7NO4 详情 详情
(VII) 63586 1-({(E)-[5-(4-nitrophenyl)-2-furyl]methylidene}amino)-2,4-imidazolidinedione C14H10N4O5 详情 详情

合成路线12

该中间体在本合成路线中的序号:(II)

By reaction of 2-aminocyclopent-1-ene-1-carbonitrile (I) with cyclohexanone (II) in presence of polyphosphoric acid in benzene followed by treatment with hydrochloric acid in ethanol.

1 (Nauchno-Issledovatelsky Institut); 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline monohydrate hydrochloride as stimulant of neuro-muscular transmission of smooth muscles. US 4550113 .
2 Lavretskaya, E.F.; Upadysheva, A.V.; Znamenskaya, A.P.; Sukhanova, S.A.; Grigorieva, N.D.; Penke, I.K.; Timofeeva, A.K. (Nauchno-Issledovatelsky Institut); Pharmaceutical preparation for learning stimulation and memory improvement. GB 2192129; US 4735953 .
3 Graul, A.; Castaner, J.; Prous, J.; NIK-247. Drugs Fut 1994, 19, 4, 343.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11242 2-Amino-1-cyclopentene-1-carbonitrile C6H8N2 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(VI) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情

合成路线13

该中间体在本合成路线中的序号:(VI)

By reaction of 2-aminocyclopent-1-ene-1-carbonitrile (I) with cyclohexanone (II) in presence of polyphosphoric acid in benzene followed by treatment with hydrochloric acid in ethanol.

1 (Nauchno-Issledovatelsky Institut); 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline monohydrate hydrochloride as stimulant of neuro-muscular transmission of smooth muscles. US 4550113 .
2 Lavretskaya, E.F.; Upadysheva, A.V.; Znamenskaya, A.P.; Sukhanova, S.A.; Grigorieva, N.D.; Penke, I.K.; Timofeeva, A.K. (Nauchno-Issledovatelsky Institut); Pharmaceutical preparation for learning stimulation and memory improvement. GB 2192129; US 4735953 .
3 Graul, A.; Castaner, J.; Prous, J.; NIK-247. Drugs Fut 1994, 19, 4, 343.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11242 2-Amino-1-cyclopentene-1-carbonitrile C6H8N2 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(VI) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情

合成路线14

该中间体在本合成路线中的序号:(II)

By cyclocondensation of 2-aminobenzonitrile (I) with cyclohexanone (II) by means of ZnCl2 at high temperature.

1 Morrison, L.; et al.; Tetrahedron Lett 1963, 20, 4, 1277-1281.
2 Castaner, R.M.; Serradell, M.N.; Castaner, J.; Tacrine. Drugs Fut 1987, 12, 11, 1032.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 19493 2-aminobenzonitrile 1885-29-6 C7H6N2 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情

合成路线15

该中间体在本合成路线中的序号:(II)

By cyclocondensation of isatine (V) with cyclohexanone (II) and aqueous concentrated NH3 at 150 C in a pressure vessel to acridine-9-carboxamide (VI), followed by a Hoffman degradation with Br2 and sodium methoxide in methanol

1 Haslinger, B.; et al.; J Chem Listy 1957, 51, 5, 1906.
2 Greenspan, S.; et al.; J Collect Czech Chem Commun 1958, 23, 10, 1319.
3 Bielavsky, J.; Analogues of 9-amino-1,2,3,4-tetrahydroacridine. Coll Czech Chem Commun 1977, 42, 2802-7.
4 Castaner, R.M.; Serradell, M.N.; Castaner, J.; Tacrine. Drugs Fut 1987, 12, 11, 1032.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(V) 14098 2,3-Indolinedione; 1H-Indole-2,3-dione; Isatin 91-56-5 C8H5NO2 详情 详情
(VI) 28179 1,2,3,4-tetrahydro-9-acridinecarboxamide C14H14N2O 详情 详情

合成路线16

该中间体在本合成路线中的序号:(VI)

This compound can be prepared by two different methods: 1) By cyclocondensation of p-anisidine (I) with 2-oxocyclohexanecarboxylate (II) to 7-methoxy-1,2,3,4-tetrahydroacridone (III), which by treatment with refluxing POCl3 is converted to 9-chloro-7-methoxy-1,2,3,4-tetrahydroacridine (IV). This compound is converted to final product by treatment with NH3 in refluxing p-cresol. 2) By cyclocondensation of 5-methoxyisatin (V) and cyclohexanone (VI) in concentrated aqueous ammonia at 150 C to 7-methoxy-1,2,3,4-tetrahydroacridine-9-carboxamide (VII), followed by a Hoffman degradation with potassium hypobromite.

1 Sigal, M.V. Jr.; Brent, B.J.; Marchini, P.; 7,8,9,10-Tetrahalo-6H-cyclohepta[b]quinolines. US 3232945 .
2 Bielavsky, J.; Analogues of 9-amino-1,2,3,4-tetrahydroacridine. Coll Czech Chem Commun 1977, 42, 2802-7.
3 Dejmek, L.; 7-MEOTA. Drugs Fut 1990, 15, 2, 126.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
37678 p-cresol 106-44-5 C7H8O 详情 详情
(I) 10478 p-Anisidine; 4-Methoxyaniline; 4-Methoxyphenylamine 104-94-9 C7H9NO 详情 详情
(II) 11889 ethyl 2-oxocyclohexanecarboxylate; Ethyl 2-cyclohexanonecarboxylate 1655-07-8 C9H14O3 详情 详情
(III) 11890 7-Methoxy-1,3,4,10-tetrahydro-9(2H)-acridinone C14H15NO2 详情 详情
(IV) 11891 9-Chloro-5,6,7,8-tetrahydro-2-acridinyl methyl ether; 9-Chloro-7-methoxy-1,2,3,4-tetrahydroacridine C14H14ClNO 详情 详情
(V) 11892 5-Methoxy-1H-indole-2,3-dione 39755-95-8 C9H7NO3 详情 详情
(VI) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(VII) 11894 7-Methoxy-1,2,3,4-tetrahydro-9-acridinecarboxamide C15H16N2O2 详情 详情

合成路线17

该中间体在本合成路线中的序号:(II)

The intermediate 2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-amine (IV) has been obtained by two different ways: The cyclization of the bicyclic isatin (I) with cyclohexanone, NH4OH and NH4OAc in methanol gives 2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-carboxamide (III), which is submitted to a Hofmann rearrangement by means of Br2 and NaOH in water to yield the intermediate amine (IV). The cyclization of 2-amino-4,5-dimethylfuran-3-carbonitrile (V) with cyclohexanone (II) by means of ZnCl2 in hot xylene or nitrobenzene gives directly the intermediate amine (IV). Finally, amine (IV) is condensed with 2-(2-oxopyrrolidin-1-yl)acetic acid methyl ester (VI) by means of NaH in NMP to provide the target amide.

1 Chaki, H.; et al.; Design and syntheses of 4-acylaminopyridine derivatives: Novel high affinity choline uptake enhancers II. Bioorg Med Chem Lett 1995, 5, 14, 1495.
2 Ninomiya, K.; Saito, K.; Sugano, M.; Tobe, A.; Morinaka, Y.; Bessho, T.; Harada, H. (Mitsubishi Chemical Corp.); 4-Acylaminopyridine derivs.. EP 0427636; JP 1991151366; JP 1991218360; JP 1991218361; US 5397785; US 5536728; US 5861411 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54257 2,3-dimethyl-6,6a-dihydro-3aH-furo[2,3-b]pyrrole-4,5-dione n/a C8H9NO3 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 54258 2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinoline-4-carboxamide n/a C14H16N2O2 详情 详情
(IV) 54259 2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-amine; 2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-ylamine n/a C13H16N2O 详情 详情
(V) 54260 2-Amino-4,5-dimethylfuran-3-carbonitrile 5117-88-4 C7H8N2O 详情 详情
(VI) 16475 Methyl 2-oxo-1-pyrrolidineacetate; Methyl 2-(2-oxo-1-pyrrolidinyl)acetate 59776-88-4 C7H11NO3 详情 详情

合成路线18

该中间体在本合成路线中的序号:(II)

Treatment of carboxylic acid (I) with refluxing cyclohexanone (II) and H2SO4 affords derivative (III), which is then condensed with propargyl bromide (IV) by means of NaH in DMF to yield propargyl ether (V). Treatment of (V) with Et3N in toluene followed by condensation with 4-cloro-iodobenzene (VI) by means of PdCl2, PPh3 and CuI provides propinyloxy derivative (VII), which is then converted into propenyloxy derivative (VIII) by hydrogenation over Pd/ BaSO4 in pyridine. Opening of the lactone ring of (VIII) by means of NaH in MeOH and THF affords methyl ester (IX), which is then condensed with benzoyl chloride (X) by means of DMAP and Et3N in CH2Cl2 to give benzoate (XI). Treatment of (XI) with Et2Zn and chloroiodomethane in dichloroethane (or alternatively in CH2Cl2 or THF) followed by recrystallization from isopropanol furnishes cyclopropane derivative (XII), which is then hydrolyzed by treatment with NaOH in dioxane to yield alcohol (XIII). Finally, (XIII) is condensed with intermediate (XIV) by means of NaH in DMF and then deprotected by treatment with HCl in dioxane to afford the target compound.

1 Hemmerle, H.; Schindler, P.; Herling, A. (Aventis SA); Derivs. of substd. cyclohexane, their process of preparation and their application for the treatment of diseases. EP 0587088; JP 1994211736; US 5463062 .
2 Hemmerle, H.; Schubert, G.; Burger, H.-J.; Herling, A.; Efendic, S. (Aventis SA); Cyclohexane derivs., processes for their preparation and their use as glucose-6-phosphatase inhibitors. CA 2149007; CA 4416433; EP 0682024; JP 1995330767; US 5739147 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 44864 Quinic acid; 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid C7H12O6 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 44855   C13H18O5 详情 详情
(IV) 11176 3-Bromopropyne; 3-Bromo-1-propyne 106-96-7 C3H3Br 详情 详情
(V) 44856   C16H20O5 详情 详情
(VI) 19395 1-chloro-4-iodobenzene 637-87-6 C6H4ClI 详情 详情
(VII) 44857   C22H23ClO5 详情 详情
(VIII) 44858   C22H25ClO5 详情 详情
(IX) 44859   C23H29ClO6 详情 详情
(X) 10463 Benzoyl chloride 98-88-4 C7H5ClO 详情 详情
(XI) 44860   C30H33ClO7 详情 详情
(XII) 44861   C31H35ClO7 详情 详情
(XIII) 44862   C23H29ClO6 详情 详情
(XIV) 44863   C17H12N6O 详情 详情

合成路线19

该中间体在本合成路线中的序号:(XII)

The reaction of 2-hydroxybenzamide (XI) with cyclohexanone (XII) by means of Ts-OH in toluene gives the spiranic benzoxazine (XIII), which is condensed with 2-bromopropionyl bromide (XIV) by means of pyridine in toluene, yielding the corresponding acylated benzoxazine (XV). The condensation of (XV) with chiral azetidinone (XVI) by means of Zn in refluxing THF affords the adduct (XVII), which is finally hydrolyzed with LiOH and H2O2 to furnish the target azetidinonepropionic acid (I).

1 Lu, X.; et al.; Process development on (3S,4S)-[(R)-1'((tert-butyldimethylsilyl)oxy)ethyl]-4-[(R)-1-carboxyethyl]-2-azetidinone: 1-beta-methylcarbapanem key intermediate. Org Process Res Dev 2001, 5, 2, 186.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30029 (2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]propionic acid C14H27NO4Si 详情 详情
(XI) 14652 salicylamide 65-45-2 C7H7NO2 详情 详情
(XII) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(XIII) 46246   C13H15NO2 详情 详情
(XIV) 13127 2-Bromopropionyl bromide; 2-Bromopropanoyl bromide 563-76-8 C3H4Br2O 详情 详情
(XV) 37738 3-(2-Bromo-1-oxopropyl)-spiro[2H-1,3-benzoxazine-2,1'-cyclohexan]-4(3H)-one 158299-05-9 C16H18BrNO3 详情 详情
(XVI) 11687 (2R,3R)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetanyl acetate C13H25NO4Si 详情 详情
(XVII) 46247   C27H40N2O5Si 详情 详情

合成路线20

该中间体在本合成路线中的序号:(VIII)

Racemic cyclohexylphenyl glycolic acid (CHPGA) (I) is dissolved with (L)-tyrosine methyl ester (II) in refluxing acetonitrile/water to yield a mixture of diastereomeric salts, which is resolved by crystallization to afford the desired diastereomeric salt [(S)-CHPGA-(L)-TME] (III). Finally, the hydrolysis of salt (III) with HCl or H2SO4 at 40-50ºC in toluene yields the enantiomer (IV). Alternatively intermediate (IV) can be obtained as follows: acetalization of (S)-mandelic acid (V) with pivaldehyde (VI) in pentane and catalytic TfOH provides derivative (VII), which is then treated with LHMDS and then condensed with cyclohexanone (VIII) in THF to furnish aldol adduct (IX). Elimination of tertiary alcohol in (IX) with SOCl2 and pyridine in THF gives derivative (X), which is then converted into intermediate (IV) either by first hydrolysis of lactone (X) with KOH in MeOH and subsequent hydrogenation of the obtained derivative (XI) over Pd/C in MeOH, or by first hydrogenation of (X) over Pd/C in MeOH to give (XII), followed by hydrolysis with KOH in MeOH. On turn, derivative (XII) can alternatively be synthesized by treatment of derivative (VII) with LHMDS, followed by reaction with 3-bromocyclohexene (XIII) in THF to provide derivative (XIV), which is then hydrogenated over Pd/C.

1 Grover, P.T.; et al.; Chiral mandelic acid template provides a highly practical solution for (S)-oxybutynin synthesis. J Org Chem 2000, 65, 19, 6283.
2 Senanayake, C.H.; Bakale, R.P.; Vandenbossche, C.P.; McConville, F.X.; Lopez, J.L. (Sepracor Inc.); Synthesis of optically active cyclohexylphenylglycolic acid and its esters. US 5973182; US 6140529; WO 0023414 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Ia) 51214 (2R)-2-cyclohexyl-2-hydroxy-2-phenylethanoic acid C14H18O3 详情 详情
(Ib),(IV) 51215 (2S)-2-cyclohexyl-2-hydroxy-2-phenylethanoic acid C14H18O3 详情 详情
(II) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(III) 51216   n/a C24H31NO6 详情 详情
(V) 12563 (2S)-2-Hydroxy-2-phenylethanoic acid; S-(+)-Mandelic acid 17199-29-0 C8H8O3 详情 详情
(VI) 19797 Trimethylacetaldehyde; pivalaldehyde; 2,2-Dimethylpropionaldehyde; 2,2-Dimethylpropanal 630-19-3 C5H10O 详情 详情
(VII) 31681 (2R,5R)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one C13H16O3 详情 详情
(VIII) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(IX) 51217 (2S,5R)-2-(tert-butyl)-5-(1-hydroxycyclohexyl)-5-phenyl-1,3-dioxolan-4-one C19H26O4 详情 详情
(X) 51218 (2S,5S)-2-(tert-butyl)-5-(1-cyclohexen-1-yl)-5-phenyl-1,3-dioxolan-4-one C19H24O3 详情 详情
(XI) 51219 (2S)-2-(1-cyclohexen-1-yl)-2-hydroxy-2-phenylethanoic acid C14H16O3 详情 详情
(XII) 51220 (2S,5S)-2-(tert-butyl)-5-cyclohexyl-5-phenyl-1,3-dioxolan-4-one C19H26O3 详情 详情
(XIII) 30800 3-bromo-1-cyclohexene 1521-51-3 C6H9Br 详情 详情
(XIV) 51221 (2S,5S)-2-(tert-butyl)-5-[(1R)-2-cyclohexen-1-yl]-5-phenyl-1,3-dioxolan-4-one C19H24O3 详情 详情

合成路线21

该中间体在本合成路线中的序号:(IV)

Reaction of 4,6-dimethylpyridin-2-amine (I) with isoamyl nitrite and HCl gives 2-chloro-4,6-dimethylpyridine (II), which is treated with hydrazine in diethylene glycol at 140 C yielding 2-hydrazino-4,6-dimethylpyridine (III). Cyclization of (III) with cyclohexanone (IV) in refluxing diethylene glycol affords the tetrahydro-alpha-carboline (V), which is dehydrogenated with Pd in refluxing diethylene glycol, giving the alpha-carboline (VI). The alkylation of (VI) with the benzyl bromide (VII) by means of potassium tert-butoxide in DMF yields the adduct (VIII), which is hydrolyzed with concentrated H2SO4 to provide the carboxylic acid (IX). Finally, this acid is condensed with (R)-2-hydroxy-1-phenylethylamine (X) by means of HOBT and EDC in CH2Cl2, giving a diastereomeric mixture of the corresponding amides that is resolved by column chromatography. The benzyl bromide intermediate (VII) has been obtained as follows: Esterification of 2-(4-methylphenyl)acetic acid (XI) with tert-butanol and DCC and DMAP in CH2Cl2 gives the corresponding tert-butyl ester (XII), which is condensed with cyclopentyl bromide (XIII) by means of t-BuOK in DMF to yield racemic 2-cyclopentyl-2-(4-methylphenyl)acetic acid tert-butyl ester (XIV). Finally, this compound is brominated with NBS and AIBN in refluxing CCl4.

1 Castañer, J.; Silvestre, J.S.; Sorbera, L.A.; Martín, L.; Implitapide. Drugs Fut 2000, 25, 11, 1138.
2 Muller, U.; Connell, R.; Goldmann, S.; Grutzmann, R.; Beuck, M.; Bischoff, H.; Denzer, D.; Domdey-Bette, A.; Wohlfeil, S. (Bayer AG); Cycloalkano-indole- and -azaindole derivs.. CA 2159546; DE 4435477; EP 0705831; JP 1996225526; US 5684014 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 41793 4,6-dimethyl-2-pyridinamine; 4,6-dimethyl-2-pyridinylamine 5407-87-4 C7H10N2 详情 详情
(II) 41794 2-chloro-4,6-dimethylpyridine 30838-93-8 C7H8ClN 详情 详情
(III) 41795 2-hydrazino-4,6-dimethylpyridine C7H11N3 详情 详情
(IV) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(V) 41796 2,4-dimethyl-6,7,8,9-tetrahydro-5H-pyrido[2,3-b]indole C13H16N2 详情 详情
(VI) 41797 2,4-dimethyl-9H-pyrido[2,3-b]indole C13H12N2 详情 详情
(VII) 41798 tert-butyl 2-[4-(bromomethyl)phenyl]-2-cyclopentylacetate C18H25BrO2 详情 详情
(VIII) 41799 tert-butyl 2-cyclopentyl-2-[4-[(2,4-dimethyl-9H-pyrido[2,3-b]indol-9-yl)methyl]phenyl]acetate C31H36N2O2 详情 详情
(IX) 41800 2-cyclopentyl-2-[4-[(2,4-dimethyl-9H-pyrido[2,3-b]indol-9-yl)methyl]phenyl]acetic acid C27H28N2O2 详情 详情
(X) 14376 (2R)-2-amino-2-phenyl-1-ethanol; (R)-(-)-2-phenylglycinol; (R)-2-amino-2-phenyl-1-ethanol 56613-80-0 C8H11NO 详情 详情
(XI) 28316 2-(4-methylphenyl)acetic acid 622-47-9 C9H10O2 详情 详情
(XII) 41801 tert-butyl 2-(4-methylphenyl)acetate C13H18O2 详情 详情
(XIII) 10792 Butanoyl chloride; Butyryl chloride 141-75-3 C4H7ClO 详情 详情
(XIV) 41802 tert-butyl 2-cyclopentyl-2-(4-methylphenyl)acetate C18H26O2 详情 详情

合成路线22

该中间体在本合成路线中的序号:(II)

Reaction of quinic acid (I) with boiling cyclohexanone (II) and a trace of H2SO4 under azeotropical removal of water gave lactone-ketal (III). Subsequent alkylation with bromide (IV) and NaH in DMF at r.t. provided ether (V), which was hydrolyzed with NaOH in aqueous dioxan to produce the sodium carboxylate (VI). Protected 4-hydroxycinnamic acid (VII) was converted to the imidazolide (VIII) on treatment with carbonyl diimidazole (CDI) in DMF, and this was subsequently condensed with (VI) in the presence of NaH in DMF to afford ester (IX). Finally, deprotection of acetal and silylethoxymethyl groups with HCl in aqueous dioxan at r.t. provided the target compound.

1 Hemmerle, H.; Schindler, P.; Herling, A. (Aventis SA); Derivs. of substd. cyclohexane, their process of preparation and their application for the treatment of diseases. EP 0587088; JP 1994211736; US 5463062 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11524 D-Quinic acid; D-(-)-Chinic acid; D-(-)-Quinic acid; (3R,5R)-1,3,4,5-Tetrahydroxycyclohexanecarboxylic acid 77-95-2 C7H12O6 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 18750 (3'aR,4'R,7'S,8'aR)-7'-Hydroxyspiro[cyclohexane-1,2'-[4,7]methanoperhydro[1,3]dioxolo[4,5-c]oxepin]-6'-one C13H18O5 详情 详情
(IV) 18751 1-[(1S,2R)-2-(bromomethyl)cyclopropyl]-4-chlorobenzene C10H10BrCl 详情 详情
(V) 18752 (3'aR,4'R,7'S,8'aR)-7'-[2(S)-(4-Chlorophenyl)cycloprop-1(R)-ylmethoxy]spiro[cyclohexane-1,2'-[4,7]methanoperhydro[1,3]dioxolo[4,5-c]oxepin]-6'-one C23H27ClO5 详情 详情
(VI) 18753 (3'aR,5'S,7'R,7'aR)-5'-[2(S)-(4-Chlorophenyl)cycloprop-1(R)-ylmethoxy]-7'-hydroxyspiro[cyclohexane-1,2'-perhydro[1,3]benzodioxole]-5-carboxylic acid sodium salt C23H28ClNaO6 详情 详情
(VII) 18754 (E)-3-(4-[[2-(trimethylsilyl)ethoxy]methoxy]phenyl)-2-propenoic acid C15H22O4Si 详情 详情
(VIII) 18755 (E)-1-(1H-imidazol-1-yl)-3-(4-[[2-(trimethylsilyl)ethoxy]methoxy]phenyl)-2-propen-1-one C18H24N2O3Si 详情 详情
(IX) 18756 (3'aR,5'S,7'R,7'aR)-5'-[2(S)-(4-Chlorophenyl)cycloprop-1(R)-ylmethoxy]-7'-[3-[4-[2-(trimethylsilyloxy)ethoxymethoxy]phenyl]-2(E)-propeneoyloxy]spiro[cyclohexane-1,2'-perhydro[1,3]benzodioxole]-5-carboxylic acid C38H49ClO9Si 详情 详情

合成路线23

该中间体在本合成路线中的序号:(II)

Anthranitic acid (I) is reacted with cyclohexanone (II) to give 5-hydroxy-1,2,3,4-tetrahydroacridine (III). The hydroxy compound (III) is then reacted with phosphorous oxychloride to give 5-chloro-1,2,3,4-tetrahydroacridine (IV). Aminolysis of (IV) with n-butylamine affords centbucridine.

1 Arya, V.P.; Centbucridine. Drugs Fut 1980, 5, 6, 281.
2 Patnaik, G.K.; et al.; Studies in 4-substituted 2,3-polymethylene quinolines. CNS Drugs Ed. G.S. Sidhu, CSI, New Delhi .
3 Patnaik, G.K.; et al.; Compounds acting on the central nervous system. IV. 4-substituted 2,3-polymethylenequinolines. J Med Chem 1966, 9, 4, 483.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 39041 butylamine; 1-butanamine 109-73-9 C4H11N 详情 详情
(I) 11661 2-Aminobenzoic acid;Anthranilic acid; o-Aminobenzoic acid 118-92-3 C7H7NO2 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 39040 1,2,3,4-tetrahydro-9-acridinol C13H13NO 详情 详情
(IV) 28181 9-chloro-1,2,3,4-tetrahydroacridine C13H12ClN 详情 详情

合成路线24

该中间体在本合成路线中的序号:(I)

The condensation between cyclohexanone (I) and dimethyl itaconate (II) in the presence of NaOMe in cold Et2O afforded the spirobutenolide (III) together with some hydrolyzed product (IV). A further hydrolytic treatment with aqueous NaOH provided acid (IV), which was then converted to acid chloride (V) by treatment with PCl5 in refluxing cyclohexane. Reaction of this acid chloride with N-(2-methoxyphenyl)piperazine in CH2Cl2 at 0 C produced the title amide.

1 Bador, P.; et al.; Synthesis of acetylenic spirobutenolide derivatives and evaluation of their growth inhibitory effect on cells in culture. Arzneim-Forsch Drug Res 1990, 40(II), 10, 1135-1139.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(II) 21416 dimethyl 2-methylenesuccinate 617-52-7 C7H10O4 详情 详情
(II) 21417 methyl 3-methyl-2-oxo-1-oxaspiro[4.5]dec-3-ene-4-carboxylate C12H16O4 详情 详情
(IV) 21418 3-methyl-2-oxo-1-oxaspiro[4.5]dec-3-ene-4-carboxylic acid C11H14O4 详情 详情
(V) 21419 3-methyl-2-oxo-1-oxaspiro[4.5]dec-3-ene-4-carbonyl chloride C11H13ClO3 详情 详情
(VI) 11882 1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine 35386-24-4 C11H16N2O 详情 详情

合成路线25

该中间体在本合成路线中的序号:(I)

The condensation between cyclohexanone (I) and dimethyl itaconate (II) in the presence of NaOMe in cold Et2O afforded the spirobutenolide (III) together with some hydrolyzed product (IV). A further hydrolytic treatment with aqueous NaOH provided acid (IV), which was then converted to acid chloride (V) by treatment with PCl5 in refluxing cyclohexane. Reaction of this acid chloride with N-(4-fluorophenyl)piperazine in CH2Cl2 at 0 C produced the title amide.

1 Bois, F.; et al.; Spirobutenolides substituted by arylpiperazinyl-carbonyl moieties. Synthesis and antinociceptive properties. Arzneim-Forsch Drug Res 1998, 48, 12, 1156.
2 Bador, P.; et al.; Synthesis of acetylenic spirobutenolide derivatives and evaluation of their growth inhibitory effect on cells in culture. Arzneim-Forsch Drug Res 1990, 40(II), 10, 1135-1139.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(II) 21416 dimethyl 2-methylenesuccinate 617-52-7 C7H10O4 详情 详情
(III) 21417 methyl 3-methyl-2-oxo-1-oxaspiro[4.5]dec-3-ene-4-carboxylate C12H16O4 详情 详情
(IV) 21418 3-methyl-2-oxo-1-oxaspiro[4.5]dec-3-ene-4-carboxylic acid C11H14O4 详情 详情
(V) 21419 3-methyl-2-oxo-1-oxaspiro[4.5]dec-3-ene-4-carbonyl chloride C11H13ClO3 详情 详情
(VI) 12143 1-(4-Fluorophenyl)piperazine 2252-63-3 C10H13FN2 详情 详情

合成路线26

该中间体在本合成路线中的序号:(I)

The condensation of cyclohexanone (I) with ethyl cyanacetate (II) gives the cyclohexylidene derivative (II), which is cyclized with N-benzylglycine (IV) and formal-dehyde by means of TEA in refluxing benzene yielding the spiro derivative (V). The decarboxylative hydrolysis of (V) with refluxing 6N HCl affords 2-benzyl-2-azaspiro [4,5]decane-4-carboxylic acid (VI), which is esterified with methanol/HCl giving the methyl ester (VII). The debenzylation of (VII) with H2 over Pd(OH)2 in methanol yields 2-azaspiro[4.5]decane-4-carboxylic acid methyl ester (VIII), which is reprotected with benzyl chloroformate and pyridine to provide the carbamate (IX). The hydrolysis of the methyl ester group of (IX) with NaOH in dioxane/water afford the protected carboxylic acid (Xa-b) as a racemic mixture that is treated with oxalyl chloride in dichloromethane to give the acyl chloride (XIa-b). The condensation of (XIa-b) with the chiral (R)(+)-1-(2-naphthyl)ethylamine (XII) yields the amide (XIIIa-b) as a diastereomeric mixture that is resolved by flash chromatography providing chiral (XIV) as a single diastereomer. Finally, this compound is hydrolyzed and deprotected with 6N HCl in refluxing THF.

1 Singh, L.; Bryans, J.S.; Receveur, J.-M.; Horwell, D.C.; Field, M.J.; Synthesis and biological evaluation of conformationally restricted gabapentin analogues. Bioorg Med Chem Lett 1999, 9, 16, 2329.
2 Horwell, D.C.; Bryans, J.S.; Receveur, J.-M. (Pfizer Inc.); Conformationally constrained amino acid cpds. having affinity for the alpha2delta subunit of a calcium channel. WO 9961424 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
10101 Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene 501-53-1 C8H7ClO2 详情 详情
(Xa) 38351 (4S)-2-[(benzyloxy)carbonyl]-2-azaspiro[4.5]decane-4-carboxylic acid C18H23NO4 详情 详情
(Xb) 38352 (4R)-2-[(benzyloxy)carbonyl]-2-azaspiro[4.5]decane-4-carboxylic acid C18H23NO4 详情 详情
(XIa) 38353 benzyl (4S)-4-(chlorocarbonyl)-2-azaspiro[4.5]decane-2-carboxylate C18H22ClNO3 详情 详情
(XIb) 38354 benzyl (4R)-4-(chlorocarbonyl)-2-azaspiro[4.5]decane-2-carboxylate C18H22ClNO3 详情 详情
(XIIIa) 38356 benzyl (4S)-4-([[(1R)-1-(2-naphthyl)ethyl]amino]carbonyl)-2-azaspiro[4.5]decane-2-carboxylate C30H34N2O3 详情 详情
(XIIIb), (XIV) 38357 benzyl (4R)-4-([[(1R)-1-(2-naphthyl)ethyl]amino]carbonyl)-2-azaspiro[4.5]decane-2-carboxylate C30H34N2O3 详情 详情
(I) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(II) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(III) 38345 ethyl 2-cyano-2-cyclohexylideneacetate C11H15NO2 详情 详情
(IV) 27895 N-(benzylamino)acetic acid; N-Benzylglycine; 2-(benzylamino)acetic acid 17136-36-6 C9H11NO2 详情 详情
(V) 38346 ethyl 2-benzyl-4-cyano-2-azaspiro[4.5]decane-4-carboxylate C20H26N2O2 详情 详情
(VI) 38347 2-benzyl-2-azaspiro[4.5]decane-4-carboxylic acid C17H23NO2 详情 详情
(VII) 38348 methyl 2-benzyl-2-azaspiro[4.5]decane-4-carboxylate C18H25NO2 详情 详情
(VIII) 38349 methyl 2-azaspiro[4.5]decane-4-carboxylate C11H19NO2 详情 详情
(IX) 38350 2-benzyl 4-methyl 2-azaspiro[4.5]decane-2,4-dicarboxylate C19H25NO4 详情 详情
(XII) 38355 (1R)-1-(2-naphthyl)-1-ethanamine; (1R)-1-(2-naphthyl)ethylamine C12H13N 详情 详情

合成路线27

该中间体在本合成路线中的序号:(II)

Lithiation of 1-cyano-5-methoxybenzocyclobutane (I), followed by addition of cyclohexanone (II), provided the 1-hydroxycyclohexyl adduct (III). The cyano group of (III) was then reduced to amine (IV) using LiAlH4. Reductive alkylation of amine (IV) with formaldehyde and NaBH3CN furnished the corresponding dimethylamino derivative, which was then converted to the corresponding hydrochloride salt with ethereal HCl.

1 Brocco, M.; Harmange, J.-C.; Peglion, J.-L.; Dessinges, A.; Newman-Tancredi, A.; Millan, M. (ADIR et Cie.); Benzocyclobutan cpds., their process for preparation and pharmaceutical compsns. containing them. CA 2264372; EP 0940386; FR 2775687; JP 1999310557; US 6107345 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 51858 4-methoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile C10H9NO 详情 详情
(II) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(III) 51859 7-(1-hydroxycyclohexyl)-4-methoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile C16H19NO2 详情 详情
(IV) 51860 1-[7-(aminomethyl)-4-methoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]cyclohexanol C16H23NO2 详情 详情

合成路线28

该中间体在本合成路线中的序号:(XLIX)

The previously referenced vinyl iodide intermediate (XXXIV) was obtained as follows: The reaction of L-mannonic acid gamma-lactone (XLVIII) with cyclohexanone (XLIX) by means of H2SO4 in toluene gave the bis-cyclohexylidene ketal (L), which was reduced with DIBAL in dichloromethane to yield the lactol (LI). The condensation of (LI) with the phosphonium chloride (LII) by means of t-Bu-OK in refluxing THF afforded the vinyl ether (LIII), which was hydroxylated with OsO4 and dihydroquinidine-4-chlorobenzoate as chiral ligand and acylated with acetic anhydride and pyridine to provide the diacetate (LIV). The condensation of (LIV) with the functionalized allyl silane (LV) by means of BF3/Et2O in acetonitrile gave the adduct (LVI), which was submitted to cyclization by means of Triton B(OMe) in THF/methyl acetate to yield the perhydropyrano[3,2-b]pyran derivative (LVII). The selective hydrolysis of the exocyclic cyclohexylidene ketal of (LVII) with hot AcOH/water afforded the diol (LVIII), which by oxidative cleavage with NaIO4 in THF afforded the aldehyde (LIX). The coupling of (LIX) with the silylated vinyl iodide (LX), catalyzed by NiCl2 and CrCl2 in DMSO, gave the silylated allyl alcohol (LXI), which was submitted to cleavage of the cyclohexylidene ketal by means of AcOH/TFA to yield the trihydroxy compound (LXII). The protection of the three OH groups of (LXII) with Tbdms-OTf and lutidine in dichloromethane afforded the tris-Tbdms protected vinyl silane (LXIII), which was finally iodinated with N-iodosuccinimide (NIS) in acetonitrile/chloroacetonitrile to provide the target vinyl iodide intermediate (XXXIV).

1 Kishi, Y.; Stamos, D.P.; Synthetic studies on halichondrins: A practical synthesis of the C.1-C.13 segment. Tetrahedron Lett 1996, 37, 48, 8643.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXXIV) 48420 methyl 2-[(2R,4aS,6S,7R,8S,8aS)-7,8-bis[[tert-butyl(dimethyl)silyl]oxy]-6-((1S,2E)-1-[[tert-butyl(dimethyl)silyl]oxy]-3-iodo-2-propenyl)octahydropyrano[3,2-b]pyran-2-yl]acetate C32H63IO7Si3 详情 详情
(XLVIII) 25665 (3R,4S,5S)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxydihydro-2(3H)-furanone C6H10O6 详情 详情
(XLIX) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(L) 52411   C18H26O6 详情 详情
(LI) 52412   C18H28O6 详情 详情
(LII) 39163 (methoxymethyl)(triphenyl)phosphonium chloride 4009-98-7 C20H20ClOP 详情 详情
(LIII) 52413   C20H32O6 详情 详情
(LIV) 52414   C23H34O9 详情 详情
(LV) 52423 methyl 3-(trimethylsilyl)-4-pentenoate C9H18O2Si 详情 详情
(LVI) 52415   C27H40O9 详情 详情
(LVII) 52416   C25H38O8 详情 详情
(LVIII) 52417   C19H30O8 详情 详情
(LIX) 52418   C18H26O7 详情 详情
(LX) 52419 (2-iodoethenyl)(trimethyl)silane C5H11ISi 详情 详情
(LXI) 52420   C23H38O7Si 详情 详情
(LXII) 52421 methyl 2-{(2R,4aS,6S,7S,8R,8aR)-7,8-dihydroxy-6-[(E)-1-hydroxy-3-(trimethylsilyl)-2-propenyl]octahydropyrano[3,2-b]pyran-2-yl}acetate C17H30O7Si 详情 详情
(LXIII) 52422 methyl 2-{(2R,4aS,6S,7R,8S,8aS)-7,8-bis{[tert-butyl(dimethyl)silyl]oxy}-6-[(1S,2E)-1-{[tert-butyl(dimethyl)silyl]oxy}-3-(trimethylsilyl)-2-propenyl]octahydropyrano[3,2-b]pyran-2-yl}acetate C35H72O7Si4 详情 详情

合成路线29

该中间体在本合成路线中的序号:(LII)

The previously referenced vinyl iodide intermediate (XXXIV) was obtained as follows: The reaction of L-mannonic acid gamma-lactone (LI) with cyclohexanone (LII) by means of H2SO4 in toluene gave the bis-cyclohexylidene ketal (LIII), which was reduced with DIBAL in dichloromethane to yield the lactol (LIV). The condensation of (LIV) with the phosphonium chloride (LV) by means of t-Bu-OK in refluxing THF afforded the vinyl ether (LVI), which was hydroxylated with OsO4 and dihydroquinidine-4-chlorobenzoate as chiral ligand and acylated with acetic anhydride and pyridine to provide the diacetate (LVII). The condensation of (LVII) with the functionalized allyl silane (LVIII) by means of BF3/Et2O in acetonitrile gave the adduct (LIX), which was submitted to cyclization by means of Triton B(OMe) in THF/methyl acetate to yield the perhydropyrano[3,2-b]pyran derivative (LX). The selective hydrolysis of the exocyclic cyclohexylidene ketal of (LX) with hot HOAc/water afforded the diol (LXI), which by oxidative cleavage with NaIO4 in THF afforded the aldehyde (LXII). The coupling of (LXII) with the silylated vinyl iodide (LXIII), catalyzed by NiCl2 and CrCl2 in DMSO, gave the silylated allyl alcohol (LXIV), which was submitted to cleavage of the cyclohexylidene ketal by means of HOAc/TFA to yield the trihydroxy compound (LXV). The protection of the three OH groups of (LXV) with Tbdms-OTf and lutidine in dichloromethane afforded the tris-Tbdms protected vinyl silane (LXVI), which was finally iodinated with N-iodosuccinimide (NIS) in acetonitrile/chloroacetonitrile to provide the target vinyl iodide intermediate (XXXIV).

1 Kishi, Y.; Stamos, D.P.; Synthetic studies on halichondrins: A practical synthesis of the C.1-C.13 segment. Tetrahedron Lett 1996, 37, 48, 8643.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXXIV) 48420 methyl 2-[(2R,4aS,6S,7R,8S,8aS)-7,8-bis[[tert-butyl(dimethyl)silyl]oxy]-6-((1S,2E)-1-[[tert-butyl(dimethyl)silyl]oxy]-3-iodo-2-propenyl)octahydropyrano[3,2-b]pyran-2-yl]acetate C32H63IO7Si3 详情 详情
(LI) 25665 (3R,4S,5S)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxydihydro-2(3H)-furanone C6H10O6 详情 详情
(LII) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(LIII) 52411   C18H26O6 详情 详情
(LIV) 52412   C18H28O6 详情 详情
(LV) 39163 (methoxymethyl)(triphenyl)phosphonium chloride 4009-98-7 C20H20ClOP 详情 详情
(LVI) 52413   C20H32O6 详情 详情
(LVII) 52414   C23H34O9 详情 详情
(LVIII) 52415   C27H40O9 详情 详情
(LIX) 52423 methyl 3-(trimethylsilyl)-4-pentenoate C9H18O2Si 详情 详情
(LX) 52416   C25H38O8 详情 详情
(LXI) 52417   C19H30O8 详情 详情
(LXII) 52418   C18H26O7 详情 详情
(LXIII) 52419 (2-iodoethenyl)(trimethyl)silane C5H11ISi 详情 详情
(LXIV) 52420   C23H38O7Si 详情 详情
(LXV) 52421 methyl 2-{(2R,4aS,6S,7S,8R,8aR)-7,8-dihydroxy-6-[(E)-1-hydroxy-3-(trimethylsilyl)-2-propenyl]octahydropyrano[3,2-b]pyran-2-yl}acetate C17H30O7Si 详情 详情
(LXVI) 52422 methyl 2-{(2R,4aS,6S,7R,8S,8aS)-7,8-bis{[tert-butyl(dimethyl)silyl]oxy}-6-[(1S,2E)-1-{[tert-butyl(dimethyl)silyl]oxy}-3-(trimethylsilyl)-2-propenyl]octahydropyrano[3,2-b]pyran-2-yl}acetate C35H72O7Si4 详情 详情

合成路线30

该中间体在本合成路线中的序号:(I)

The reaction of cyclohexanone (I) with acrylonitrile (II) by means of pyrrolidine gives 3-(2-oxocyclohexyl)propionitrile (III), which is condensed with methoxymethyltriphenylphosphonium chloride (IV) in THF to yield the methoxymethylene derivative (V). The condensation of propionitrile (V) with 4-bromostyrene (VI) by means of n-BuLi ethyl ether affords the styryl ketone (VII), which is cyclized by means of triphenyl phosphite and O3 (or air, methylene blue and light) to provide trioxane (VIII) as a diastereomeric mixture that is separated by column chromatography. Finally, the vinyl group of the desired diastereomer (VIII) is oxidized with KMnO4 in acetone to afford the target compound.

1 Parker, M.H.; Krasavin, M.; Posner, G.H.; Paik, I.-H.; Jeon, H.B.; Shapiro, T.A.; Antimalarial simplified 3-aryltrioxanes: Synthesis and preclinical efficacy/toxicity testing in rodents. J Med Chem 2001, 44, 19, 3054.
2 Posner, G.H.; Shapiro, T.A.; Parker, M.H.; Krasavin, M. (Johns Hopkins University); Water-soluble trioxanes as potent and safe antimalarial agents. US 6136847; WO 0059501 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(II) 10847 Acrylonitrile 107-13-1 C3H3N 详情 详情
(III) 49235 2-(beta-Cyanoethyl)cyclohexanone C9H13NO 详情 详情
(IV) 39163 (methoxymethyl)(triphenyl)phosphonium chloride 4009-98-7 C20H20ClOP 详情 详情
(V) 49236 3-[2-[(Z)-methoxymethylidene]cyclohexyl]propanenitrile C11H17NO 详情 详情
(VI) 49237 4-Bromostyrene; p-Bromostyrene 2039-82-9 C8H7Br 详情 详情
(VII) 49238 3-[2-[(Z)-methoxymethylidene]cyclohexyl]-1-(4-vinylphenyl)-1-propanone C19H24O2 详情 详情
(VIII) 49239 (1S,6R,9S,12R)-12-methoxy-6-methyl-9-(4-vinylphenyl)-10,11,13-trioxatricyclo[7.2.2.0(1,6)]tridecane; methyl (1S,6R,9S,12R)-6-methyl-9-(4-vinylphenyl)-10,11,13-trioxatricyclo[7.2.2.0(1,6)]tridec-12-yl ether C20H26O4 详情 详情

合成路线31

该中间体在本合成路线中的序号:(III)

In a different method, acetylation of 3-amino-1,2-propanediol (I) yields the amide diol (II). Ketalization of cyclohexanone (III) with diol (II) furnishes the spiro dioxolane (IV). The acetamide function of (IV) is then hydrolyzed to amine (V) employing aqueous hydrazine. Amine (V) is condensed with N,N'-di-(carbobenzoxy)-N''-(trifluoromethylsulfonyl)guanidine (VI) to produce the protected guanidine (VII). The N-carbobenzoxy groups of (VII) are finally removed by hydrogenolysis over Pd/C. Alternatively, amine (V) is condensed with cyanogen bromide to produce the cyanamide (VIII). Then, reaction of cyanamide (VIII) with ammonium chloride in aqueous ammonia furnishes the title guanidine compound

1 Xian, M.; Li, X.; Tang, X.; Chen, X.; Zheng, Z.; Galligan, J.J.; Kreulen, D.L.; Wang, P.G.; N-Hydroxyl derivatives of guanidine based drugs as enzymatic NO donors. Bioorg Med Chem Lett 2001, 11, 17, 2377.
2 Xiao, J.-H.; et al.; Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR.RXR heterodimers to co. J Biol Chem 1995, 270, 7, 3001.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12979 3-Amino-1,2-propanediol;3-aminopropane-1,2-diol 616-30-8 C3H9NO2 详情 详情
(II) 62352 N-(2,3-dihydroxypropyl)acetamide C5H11NO3 详情 详情
(III) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(IV) 62353 N-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)acetamide C11H19NO3 详情 详情
(V) 62351 1,4-dioxaspiro[4.5]dec-2-ylmethanamine; 1,4-dioxaspiro[4.5]dec-2-ylmethylamine C9H17NO2 详情 详情
(VI) 62354   C18H19N3O4 详情 详情
(VII) 62356 benzyl (Z)-{[(benzyloxy)carbonyl]amino}[(1,4-dioxaspiro[4.5]dec-2-ylmethyl)amino]methylidenecarbamate C26H31N3O6 详情 详情
(VIII) 62355 1,4-dioxaspiro[4.5]dec-2-ylmethylcyanamide C10H16N2O2 详情 详情

合成路线32

该中间体在本合成路线中的序号:(I)

Michael addition of acrylonitrile to the enamine resultant from cyclohexanone (I) and pyrrolidine, followed by alkylation with ethyl bromoacetate, leads to the cyano ester (II). Subsequent Wittig reaction of (II) with methoxymethylene triphenylphosphorane affords the enol ether (III). The ester group of (III) is then reduced to alcohol (IV) using L-selectride. Further intramolecular cyclization of (IV) under acidic conditions gives rise to the bicyclic compound (V). Lithiation of p-bromostyrene (VI) with tert-butyllithium, followed by addition to nitrile (V) produces the ketone adduct (VII). Photooxygenation of (VII), followed by cyclization in the presence of trimethylsilyl triflate, furnishes the fused trioxane derivative (VIII). Finally, oxidative cleavage of the vinyl group of (VIII) with potassium permanganate yields the target carboxylic acid.

1 Paik, I.-H.; Posner, G.H.; Jeon, H.B.; Shapiro, T.A.; Xie, S.; Borstnik, K.; Ploypradith, P.; Orally active, water-soluble antimalarial 3-aryltrioxanes: Short synthesis and preclinical efficacy testing in rodents. J Med Chem 2002, 45, 18, 3824.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IIIa) 57612 ethyl 2-{3-(2-cyanoethyl)-2-[(Z)-methoxymethylidene]cyclohexyl}acetate C15H23NO3 详情 详情
(IIIb) 57613 ethyl 2-{3-(2-cyanoethyl)-2-[(E)-methoxymethylidene]cyclohexyl}acetate C15H23NO3 详情 详情
(IVa) 57614 3-{(1R,3S)-3-(2-hydroxyethyl)-2-[(Z)-methoxymethylidene]cyclohexyl}propanenitrile C13H21NO2 详情 详情
(IVb) 57615 3-{(1R,3S)-3-(2-hydroxyethyl)-2-[(E)-methoxymethylidene]cyclohexyl}propanenitrile C13H21NO2 详情 详情
(I) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(II) 57611 ethyl 2-[3-(2-cyanoethyl)-2-oxocyclohexyl]acetate C13H19NO3 详情 详情
(V) 57616 3-[(4aS,8R)-4,4a,5,6,7,8-hexahydro-3H-isochromen-8-yl]propanenitrile C12H17NO 详情 详情
(VI) 49237 4-Bromostyrene; p-Bromostyrene 2039-82-9 C8H7Br 详情 详情
(VII) 57617 3-[(4aS,8R)-4,4a,5,6,7,8-hexahydro-3H-isochromen-8-yl]-1-(4-vinylphenyl)-1-propanone C20H24O2 详情 详情
(VIII) 57618 (1S,4R,8S,12R,13R)-1-(4-vinylphenyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.0~4,13~.0~8,13~]hexadecane C20H24O4 详情 详情

合成路线33

该中间体在本合成路线中的序号:(XXVI)

The tosylate precursor (I) can be prepared by a number of different methods. Microbial dihydroxylation of chlorobenzene (XIII) gives (1S,2S)-3-chlorocyclohexa-3,5-diene-1,2-diol (XIV), which is further hydrogenated to (XV) in the presence of Rh/Al 2O3. Regioselective tosylation of (XV), followed by hydrogenation of the resulting monotosylate (XVI) over Pd/C, leads to (1S,2R)-2-hydroxycyclohexyl tosylate (XVII). Subsequent coupling of (XVII) with imidate (X) provides the target intermediate (I) (1). In a different method, ketalization of (S,S)-1,2-cyclohexanediol (XVIII) with 2,2-dimethoxypropane provides the acetonide (XIX), which is oxidized to 2(S)-hydroxycyclohexanone (XX) by treatment with bis(trifluoromethyl)-dioxirane (BTDO). Subsequent tosylation of (XX) furnishes 2(S)-tosyloxycyclohexanone (XXI). Alternatively, the chiral tosyl ketone (XXI) can be obtained by monotosylation of diol (XVIII) in the presence of Bu2SnO to afford the hydroxy tosylate (XXII), which is subjected to Jones oxidation, giving ketone (XXI). The diastereoselective reduction of ketone (XXI) then provides an alternative route to 2(R)-hydroxy tosylate (XVII). Alternatively, the chiral tosyl ketone (XXI) is condensed with the sodium alkoxide of 3,4-dimethoxyphenethyl alcohol (XI) to yield the 2(R)-ether (XXIIIa). Stereoselective reduction of ketone (XXIIIa) utilizing bulky reducing agents such as L-Selectride, LS-Selectride or alpine boranes gives the (S)-cyclohexanol (XXIV), which can be further converted to tosylate (I) under the usual conditions. Similarly, the phenethyl alcohol (XI) can be reacted with 2-chlorocyclohexanone (XXV) by means of NaH to yield the racemic ketone ether (XXIIIb), which is enantioselectively reduced to the (1S,2R)-phenethoxycyclohexanol (XXIV) under Noyori’s asymmetric hydrogenation conditions. A further route to the phenethoxy ketone (XXIIIa) consists of the enantioselective α-oxyamination of cyclohexanone (XXVI) with nitrosobenzene in the presence of L-proline to produce the chiral hydroxylamine derivative (XXVII), which is subsequently cleaved to 2(R)-hydroxycyclohexanone (XXVIII) by treatment with CuSO4, and then coupled with imidate (X) in the presence of boron trifluoride etherate. Optionally, 2(R)-hydroxycyclohexanone (XXVIII) can be obtained by oxidation of the (1R,2R)-cyclohexanediol acetonide (XXIX) with BTDO. Another method for obtaining the (1S,2R)-phenethoxy cyclohexanol (XXIV) is based on the asymmetric reduction of (3,4-dimethoxyphenyl)acetaldehyde cyclohexanediol acetal (XXX) by means of triethylsilane in the presence of chiral Lewis acids (2). Scheme 2.

1 Beatch, G.N., Choi, L.S.L., Jung, G. et al. (Cardiome Pharma Corp.). Aminocyclohexyl ether compounds and uses thereof. EP 1560812, EP1666459, JP 2006525227, WO 2004099137.
2 Plouvier, B.M.C., Chou, D.T.H., Jung, G. et al. (Cardiome Pharma Corp.). Synthetic process for aminocyclohexyl ether compounds. WO 2006088525.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXIIIa) 65283     C16H22O4 详情 详情
(XXIIIb) 65284     C16H22O4 详情 详情
(I) 65263 (1S,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl tosylate   C23H30O6S 详情 详情
(X) 65272 3,4-dimethoxyphenethyl trichloroacetimidate   C12H14Cl3NO3 详情 详情
(XIII) 10190 1-Chlorobenzene 108-90-7 C6H5Cl 详情 详情
(XIV) 65274 (1S,2S)-3-chlorocyclohexa-3,5-diene-1,2-diol   C6H7ClO2 详情 详情
(XV) 65275 (1S,2S)-3-chlorocyclohexa-3-ene-1,2-diol   C6H9ClO2 详情 详情
(XVI) 65276 (1S,2S)-3-chloro-2-hydroxycyclohexa-3-ene-1-yl tosylate   C13H15ClO4S 详情 详情
(XVII) 65277 (1S,2R)-2-hydroxycyclohexyl tosylate   C13H18O4S 详情 详情
(XVIII) 65278 (1R,2R)-1,2-Cyclohexanediol 1072-86-2 C6H12O2 详情 详情
(XIX) 65279 (1S,2S)-cyclohexanediol acetonide   C9H16O2 详情 详情
(XX) 65280 (2S)-hydroxycyclohexanone   C6H10O2 详情 详情
(XXI) 65281 (2S)-tosyloxycyclohexanone   C13H16O4S 详情 详情
(XXII) 65282 (1S,2S)-2-hydroxycyclohexyl tosylate   C13H18O4S 详情 详情
(XXIV) 65285 (1S,2R)-phenethoxycyclohexanol   C16H24O4 详情 详情
(XXV) 17985 2-Chlorocyclohexanone 822-87-7 C6H9ClO 详情 详情
(XXVI) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(XXVII) 65286     C12H15NO2 详情 详情
(XXVIII) 65287 (2R)-hydroxycyclohexanone   C6H10O2 详情 详情
(XXIX) 65288 (1R,2R)-cyclohexanediol acetonide   C9H16O2 详情 详情
(XXX) 65289 (3,4-dimethoxyphenyl)acetaldehyde cyclohexanediol acetal   C16H21O4 详情 详情

合成路线34

该中间体在本合成路线中的序号:(XXVI)

The pyrrolidine building blocks are in turn synthesized as shown in Scheme 5. 3(R)-Hydroxypyrrolidine (IV) is protected as the N-Boc derivative (LIV), followed by O-alkylation with benzyl bromide and acidic deprotection of the resulting benzyl ether (LV) to furnish 3(R)-benzyloxypyrrolidine (II). Condensation of pyrrolidine (II) with cyclohexene oxide (XXXI) gives the trans-pyrrolidinocyclohexanol (LVI) as a diastereomeric mixture, which is separated either by crystallization with di-p-toluoyl-L-tartaric acid (DTTA) or by diastereoselective N-oxidation of the undesired diastereoisomer to furnish the target isomer (IX). Alternatively, intermediate (IX) can be obtained by ring opening of epoxide (XXXI) with pyrrolidine (II) in the presence of chiral catalysts. In a different strategy, enantioselective ring opening of cyclohexene oxide (XXXI) with B-bromodiisopinocamphenylborane provides the optically enriched trans-bromohydrin (LVII), which is then condensed with benzyloxypyrrolidine (II) to yield the (1S,2R)-pyrrolidinocyclohexanol (LVIII). Inversion of the configuration of alcohol (LVIII) to produce (IX) is then accomplished by Mitsunobu coupling with formic acid, followed by acidic hydrolysis of the resulting (1R,2R)-formate ester (LIX). Further synthetic strategies leading to the pyrrolidinocyclohexanol (IX) involve cyclization of (R,R)-2-aminocyclohexanol (LX) with 2(R)-benzyloxy-1,4-butanediol ditosylate (LXI), and condensation of (LX) with cyclohexanone (XXVI), followed by asymmetric hydroboration and oxidative work-up of the resulting enamine (LXII) (2). Alternatively, (R,R)-2-aminocyclohexanol (LX) can be converted to the intermediate acetoxysuccinimide (XII) by condensation with 2(R)-acetoxysuccinic anhydride (VI) (prepared from L-malic acid [LXIII] and acetyl chloride) to produce a regioisomeric mixture of succinamic acids (LXIVa) and (LXIVb), which undergoes cyclization to imide (XII) upon heating with acetyl chloride (4). Similarly, racemic trans-2-benzyloxycyclohexylamine (LXV) is resolved by enantioselective N-acylation with isopropyl methoxyacetate in the presence of lipase, followed by hydrolysis of the resulting (R,R)-methoxyacetamide (LXVI) to provide (LXVII) (5). Acylation of (R,R)-2-benzyloxycyclohexylamine (LXVII) with O-acetylmalic anhydride (VI), followed by cyclization with acetyl chloride, yields the N-(2-benzyloxycyclohexyl)succinimide (LXVIII), which is then debenzylated to (XII) by catalytic hydrogenation over Pd/C (4). Scheme 5.

2 Plouvier, B.M.C., Chou, D.T.H., Jung, G. et al. (Cardiome Pharma Corp.). Synthetic process for aminocyclohexyl ether compounds. WO 2006088525.
4 Roth, C.J., Jung, G., Plouvier, B.M.C., Chou, D.T.H., Yee, J.G.K. (Cardiome Pharma Corp.). Synthetic processes for the preparation of aminocyclohexyl ether compounds. WO 2006138673.
5 Balkenhohl, F., Ditrich, K., Nübling, C. (BASF AG). Racemate separation of primary and secondary heteroatom-substituted amine by enzyme-catalysed acylation. WO 9623894.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(LXIVa) 65319      C12H19NO6 详情 详情
(LXIVb) 65320     C12H19NO6 详情 详情
(II) 65264 (3R)-benzyloxypyrrolidine   C11H15NO 详情 详情
(IV) 14490 (3R)tetrahydro-1H-pyrrol-3-ol; R-3-hydroxypyrrolidine 2799-21-5 C4H9NO 详情 详情
(VI) 65267 (2R)-acetoxysuccinic anhydride 79814-40-7 C6H6O5 详情 详情
(VI) 51236 2,4-Dimethylpyrrole 625-82-1 C6H9N 详情 详情
(IX) 65271 (2R)-[(3R)-benzyloxy-1-pyrrolidinyl]cyclohexan-(1R)-ol   C16H25NO2 详情 详情
(XII) 65273 (2R)-acetoxy-N-[(2R)-hydroxy-(1R)-cyclohexyl]succinimide   C12H17O5 详情 详情
(XXVI) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(XXXI) 17986 7-oxabicyclo[4.1.0]heptane; cyclohexene oxide 286-20-4 C6H10O 详情 详情
(LIV) 65310 (R )-1-Boc-3-hydroxypyrrolidine; (R )-N-(tert-Butoxycarbonyl)-3-hydroxypyrrolidine; (R )-3-Hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester 103057-44-9 C9H17O3N 详情 详情
(LV) 65311     C16H23O3N 详情 详情
(LVI) 65312     C17H25NO2 详情 详情
(LVII) 65313 trans-2-bromocyclohexanol   C6H11BrO 详情 详情
(LVIII) 65314     C17H24NO2 详情 详情
(LIX) 65315     C18H25NO3 详情 详情
(LX) 65316 (1R,2R)-2-aminocyclohexanol   C6H13NO 详情 详情
(LXI) 65317     C25H28O7S2 详情 详情
(LXII) 65318     C17H23NO 详情 详情
(LXIII) 11058 (S)-(+)-Hydroxysuccinic acid; (S)-(+)-Malic acid; (S)-(+)-2-Hydroxybutanedioic acid; L-(-)-Apple acid 97-67-6 C4H6O5 详情 详情
(LXV) 65321 racemic trans-2-benzyloxycyclohexylamine   C13H17NO 详情 详情
(LXVI) 65322     C16H23NO3 详情 详情
(LXVII) 65323     C13H19NO 详情 详情
(LXVIII) 65324     C19H23NO5 详情 详情

合成路线35

该中间体在本合成路线中的序号:(III)

 

1 Gore VG, Kulkarni VS, Patil M. 2009. Process for perparation of O-desmethylvenlafaxine via treatment of venlafaxine with a thiol reagent. WO 2009053731.
2 Modi IA, Muktawat S, Singh UP, et al. 2009. Preparation of O-desmethylvenlafaxine by demethylation of venlafaxine. WO 2009034434.
3 Niddam-Hildesheim V, Nidam T, Dolitzky. 2009. Process for the synthesis of O-desmethylvenlafaxine including tridesmethylvenlafaxime as an intermediate, US 2009069601; US 2008221356.
4 Tyagi OD, Lahari S, Koilkonda P, et al. 2009.Process for producing 1-[2-(dimethylamino)-1-(4-hydroxyphenyl) ethyl] cyclohexanol. WO 20090840039.
5 Srinivasan CV, Aggarwal AK, Sarin GS, et al. 2009. Improved process for the preparation of O-desmethyl-venlafaxine. WO 2009084038.
6 Xu JK, Xu MD, Cai YX, et al.2009.Novel method for preparation of O-desvenlafaxine. 发明专利申请公开说明书. CN 101117320.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32753 2-(4-hydroxyphenyl)acetonitrile; 4-Hydroxybenzyl cyanide 14191-95-8 C8H7NO 详情 详情
(II) 67072 2-(4-(benzyloxy)phenyl)acetonitrile 英文名称为:   C15H13NO 详情 详情
(III) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(IV) 67073 2-(4-(benzyloxy)phenyl)-2-(1-hydroxycyclohexyl)acetonitrile   C21H23NO2 详情 详情
(V) 67074 1-(2-amino-1-(4-(benzyloxy)phenyl)ethyl)cyclohexanol   C21H27NO2 详情 详情

合成路线36

该中间体在本合成路线中的序号:(IV)

 

1 Gore VG, Kulkarni VS, Wakchaure VS, et al. 2008. Process for perparation of O-desmethyl venlafaxine(ODV) from phenylacetic acid derivatives, dimethylamino, and cyclohexanone. WO 2008093142.
2 Niddam-Hildesheim V, Shenkar N, Shachan-Tov S. 2008. Process for the synthesis of O-desmethylvenlafaxine from 1-[2-amino-1-(4-methoxyphenyl) ethyl] cyclohexanol via O-demethylation and N-methylation reactions. WO 2008013995.
3 Niddam-Hildesheim V, Shenkar N, Shachan-Tov S. 2008. Process for the synthesis of O-desmethylvenlafaxine from hydroxybenzyl cyanide via condensation reaction with cyclohexanone. WO 2008013993.
4 Niddam-Hildesheim V, Shenkar N, Shachan-Tov S. 2008. Process for the synthesis of O-desmethylvenlafaxine from (4-hydroxyphenyl) acetic acid. WO 2008013990.
5 Zupancic S, Skrabanja V. 2007. Process for praparation of O-desmethylvenlafaxine. WO 2007147564.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 67076 2-(4-(benzyloxy)phenyl)acetyl chloride   C15H14ClO2 详情 详情
(I) 67075 2-(4-(benzyloxy)phenyl)acetic acid   C15H14O3 详情 详情
(III) 67077 2-(4-(benzyloxy)phenyl)-N,N-dimethylacetamide   C17H20NO2 详情 详情
(IV) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(V) 67078 2-(4-(benzyloxy)phenyl)-2-(1-hydroxycyclohexyl)-N,N-dimethylacetamide   C23H30NO3 详情 详情
Extended Information